Vascular Diseases Stocks List

Recent Signals

Date Stock Signal Type
2021-02-25 ABIO Fell Below 50 DMA Bearish
2021-02-25 AMRN New Downtrend Bearish
2021-02-25 ANGO 20 DMA Support Bullish
2021-02-25 ANGO 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-25 ANGO Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-25 BCDA New Downtrend Bearish
2021-02-25 BCDA Fell Below 50 DMA Bearish
2021-02-25 CAPR New Downtrend Bearish
2021-02-25 GILD MACD Bearish Centerline Cross Bearish
2021-02-25 GILD Fell Below 50 DMA Bearish
2021-02-25 IRWD Lower Bollinger Band Walk Weakness
2021-02-25 KOD 180 Bearish Setup Bearish Swing Setup
2021-02-25 KOD Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-02-25 MESO MACD Bearish Centerline Cross Bearish
2021-02-25 MESO Stochastic Reached Oversold Weakness
2021-02-25 MESO MACD Bearish Signal Line Cross Bearish
2021-02-25 MMSI 20 DMA Resistance Bearish
2021-02-25 MMSI Expansion Pivot Sell Setup Bearish Swing Setup
2021-02-25 MMSI Wide Range Bar Range Expansion
2021-02-25 MMSI 50 DMA Resistance Bearish
2021-02-25 MMSI Stochastic Reached Oversold Weakness
2021-02-25 NBIX Stochastic Reached Oversold Weakness
2021-02-25 NBIX Fell Below 200 DMA Bearish
2021-02-25 NBIX Fell Below 50 DMA Bearish
2021-02-25 OCUP Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-25 OCUP New Downtrend Bearish
2021-02-25 REGN New Downtrend Bearish

Recent News for Vascular Diseases Stocks

Date Stock Title
Feb 26 REGN Regeneron's COVID-19 Antibody Cocktail Wins EU Positive Opinion
Feb 26 FLGT 1 Green Flag for Fulgent Genetics
Feb 26 REGN Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning
Feb 26 REGN Regeneron's antibody cocktail is set for marketing approval in EU
Feb 26 REGN UPDATE 1-EU regulator advises use of Regeneron antibody cocktail for COVID-19
Feb 26 REGN EMA Issues Advice on Regeneron's Antibody Cocktail (casirivimab with imdevimab) for Certain COVID-19 Patients
Feb 26 MMSI Should You Be Impressed By Merit Medical Systems' (NASDAQ:MMSI) Returns on Capital?
Feb 25 GILD ‘Covid-19 has been the perfect storm for adversaries’ in cybersecurity industry: CrowdStrike
Feb 25 REGN ‘Covid-19 has been the perfect storm for adversaries’ in cybersecurity industry: CrowdStrike
Feb 25 AMRN Amarin Corporation plc's (AMRN) CEO John Thero on Q4 2020 Results - Earnings Call Transcript
Feb 25 REGN Doctor: New COVID-19 strains come from ‘robust transmission of the virus’
Feb 25 GILD Positive news on COVID vaccines weighs against concerns over new variants
Feb 25 REGN Positive news on COVID vaccines weighs against concerns over new variants
Feb 25 AMRN How Amarin Beat Wall Street's Q4 Estimates
Feb 25 REGN Regeneron to share new data about COVID-19 antibody cocktail in March
Feb 25 GILD GSK to refocus study of experimental COVID-19 antibody treatment on patients 70 and older
Feb 25 AMRN Amarin Q4 results led by strong Vascepa sales
Feb 25 REGN Regeneron To Stop Giving Placebo In COVID-19 Antibody Trial After 'Clear Efficacy'
Feb 25 REGN Regeneron to stop giving placebo in COVID-19 drug trial after 'clear efficacy'
Feb 25 REGN Independent Data Monitoring Committee Finds Clear Efficacy for REGEN-COV™ (casirivimab with imdevimab) in Phase 3 COVID-19 Outpatient Outcomes Trial

Vascular disease is a class of diseases of the blood vessels – the arteries and veins of the circulatory system of the body. It is a subgroup of cardiovascular disease. Disorders in this vast network of blood vessels, can cause a range of health problems which can be severe or prove fatal.

More about Vascular Diseases
Browse All Tags